|
SEC31A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.628000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.058400E-01 |
| Normal-vs-Stage2 |
7.287600E-01 |
| Normal-vs-Stage3 |
1.584030E-01 |
| Normal-vs-Stage4 |
8.103400E-01 |
| Stage1-vs-Stage2 |
6.411600E-01 |
| Stage1-vs-Stage3 |
3.866000E-02 |
| Stage1-vs-Stage4 |
7.914200E-01 |
| Stage2-vs-Stage3 |
1.444000E-01 |
| Stage2-vs-Stage4 |
9.878400E-01 |
| Stage3-vs-Stage4 |
2.886200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.298600E-01 |
| Normal-vs-AfricanAmerican |
2.489800E-01 |
| Normal-vs-Asian |
9.621800E-01 |
| Caucasian-vs-AfricanAmerican |
4.880600E-01 |
| Caucasian-vs-Asian |
9.042000E-01 |
| AfricanAmerican-vs-Asian |
7.080400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.826600E-01 |
| Normal-vs-Female |
7.895800E-01 |
| Male-vs-Female |
4.809600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.449000E-01 |
| Normal-vs-Extreme_Weight |
1.133030E-01 |
| Normal-vs-Obese |
8.362800E-01 |
| Normal-vs-Extreme_Obese |
8.792800E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.345800E-01 |
| Normal_Weight-vs-Obese |
8.814000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.770000E-01 |
| Extreme_Weight-vs-Obese |
1.933010E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.535400E-01 |
| Obese-vs-Extreme_Obese |
8.215800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.912200E-01 |
| Normal-vs-Age(41-60Yrs) |
8.284400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.803600E-02 |
| Normal-vs-Age(81-100Yrs) |
4.833200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.282200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.120180E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.635400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.015300E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.573600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.977800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.058000E-02 |
| Normal-VS-Type2 PRCC |
4.463600E-01 |
| Normal-VS-KIRP CIMP |
9.982200E-01 |
| Normal-VS-Unclassified PRCC |
3.412600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.236300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.828800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.544300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.315200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.581200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.944200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.656600E-01 |
| Normal-vs-N1 |
5.885400E-01 |
| Normal-vs-N2 |
9.573600E-01 |
| N0-vs-N1 |
7.720600E-01 |
| N0-vs-N2 |
9.176600E-01 |
| N1-vs-N2 |
7.672200E-01 |
|
|
